Celldex Therapeutics (NASDAQ:CLDX) Issues Quarterly Earnings Results
Celldex Therapeutics (NASDAQ:CLDX – Get Free Report) released its earnings results on Thursday. The biopharmaceutical company reported ($1.18) earnings per share for the quarter, missing the consensus estimate of ($1.13) by ($0.05), FiscalAI reports. The business had revenue of $0.02 million during the quarter, compared to analysts’ expectations of $0.80 million. Celldex Therapeutics Price Performance […]
9 May 00:42 · The Cerbat Gem